Viewing Study NCT05184803


Ignite Creation Date: 2025-12-24 @ 7:40 PM
Ignite Modification Date: 2025-12-29 @ 10:08 AM
Study NCT ID: NCT05184803
Status: RECRUITING
Last Update Posted: 2024-02-28
First Post: 2021-12-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer
Sponsor:
Organization: